Julie Brahmer, MD, discusses the unique features of the phase 3 CheckMate 9LA trial in patients with metastatic non–small cell lung cancer.

Researchers have identified a new biomarker in multiple sclerosis (MS): the thickness of the inflammatory rim surrounding ...

Until prospective data are available, researchers recommend that patients with ER-low breast cancer “should be counseled regarding the potential benefit” of adjuvant endocrine therapy.

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...

A recent reanalysis of a 108-million-year-old bone challenged the consensus that echidnas and platypuses descended from a single land-bound ancestor. The aquatic life was believed to have attracted a ...

In a study from Dr. Zlotta’s group published in 2025 in the Journal of Urology, 1 they suggest that better tools are needed to minimize interobserver variability in pathological grading. This is ...

In a comprehensive Genomic Press perspective article published today, researchers from Fudan University and Shanghai ...

Scientists at Northwestern University and University of California, Santa Barbara have created the first synthetic fragment of tau protein that acts like a prion.

According to the World Health Organization, approximately one in every third of individuals is affected by neurological diseases, which pose a global health ...

Dr Susan Michaelis, the founder of the Lobular Moon Shot Project has called on Wes Streeting to fund a vital research project into lobular breast cancer like his predecessor Victoria Atkins had agreed ...